These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 7585661)

  • 41. SPARC and the extracellular matrix: implications for cancer and wound repair.
    Reed MJ; Sage EH
    Curr Top Microbiol Immunol; 1996; 213 ( Pt 1)():81-94. PubMed ID: 8814996
    [No Abstract]   [Full Text] [Related]  

  • 42. TGF beta in prostate cancer: a growth inhibitor that can enhance tumorigenicity.
    Barrack ER
    Prostate; 1997 Apr; 31(1):61-70. PubMed ID: 9108888
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Deletion of one adenine base within the polyadenine tract of transforming growth factor-beta receptor type II in human MDA-MB-231 breast cancer cell line.
    Park B; Jang JS; Park K
    Int J Oncol; 2000 Sep; 17(3):473-8. PubMed ID: 10938386
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Overexpression of transforming growth factor beta-type II receptor reduces tumorigenicity and metastastic potential of K-ras-transformed thyroid cells.
    Turco A; Coppa A; Aloe S; Baccheschi G; Morrone S; Zupi G; Colletta G
    Int J Cancer; 1999 Jan; 80(1):85-91. PubMed ID: 9935236
    [TBL] [Abstract][Full Text] [Related]  

  • 45. TGF-β signaling in liver and gastrointestinal cancers.
    Katz LH; Likhter M; Jogunoori W; Belkin M; Ohshiro K; Mishra L
    Cancer Lett; 2016 Sep; 379(2):166-72. PubMed ID: 27039259
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Transforming growth factor beta and its receptors: their role in breast cancer.
    Walker RA
    Histopathology; 2000 Feb; 36(2):178-80. PubMed ID: 10672064
    [No Abstract]   [Full Text] [Related]  

  • 47. The conventional transforming growth factor-beta (TGF-beta) receptor type I is not required for TGF-beta 1 signaling in a human prostate cancer cell line, LNCaP.
    Kim IY; Zelner DJ; Lee C
    Exp Cell Res; 1998 May; 241(1):151-60. PubMed ID: 9633523
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Genetic change in transforming growth factor beta (TGF-beta) receptor type I gene correlates with insensitivity to TGF-beta 1 in human prostate cancer cells.
    Kim IY; Ahn HJ; Zelner DJ; Shaw JW; Sensibar JA; Kim JH; Kato M; Lee C
    Cancer Res; 1996 Jan; 56(1):44-8. PubMed ID: 8548772
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Heterogeneous transforming growth factor (TGF)-beta unresponsiveness and loss of TGF-beta receptor type II expression caused by histone deacetylation in lung cancer cell lines.
    Osada H; Tatematsu Y; Masuda A; Saito T; Sugiyama M; Yanagisawa K; Takahashi T
    Cancer Res; 2001 Nov; 61(22):8331-9. PubMed ID: 11719467
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Transforming growth factor-beta: an overview.
    Lawrence DA
    Kidney Int Suppl; 1995 Jun; 49():S19-23. PubMed ID: 7674587
    [No Abstract]   [Full Text] [Related]  

  • 51. TGFβ Induces a Pro-Bone Metastasis Program in Prostate Cancer.
    Cancer Discov; 2015 Jul; 5(7):OF23. PubMed ID: 26022606
    [TBL] [Abstract][Full Text] [Related]  

  • 52. TGF-β/TGF-β receptor system and its role in physiological and pathological conditions.
    Santibañez JF; Quintanilla M; Bernabeu C
    Clin Sci (Lond); 2011 Sep; 121(6):233-51. PubMed ID: 21615335
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Autocrine growth inhibition by transforming growth factor beta-1 (TGFbeta-1) in human neuroendocrine tumour cells.
    Wimmel A; Wiedenmann B; Rosewicz S
    Gut; 2003 Sep; 52(9):1308-16. PubMed ID: 12912863
    [TBL] [Abstract][Full Text] [Related]  

  • 54. JNK regulates autocrine expression of TGF-beta1.
    Ventura JJ; Kennedy NJ; Flavell RA; Davis RJ
    Mol Cell; 2004 Jul; 15(2):269-78. PubMed ID: 15260977
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Wnt signaling induces gene expression of factors associated with bone destruction in lung and breast cancer.
    Johnson RW; Merkel AR; Page JM; Ruppender NS; Guelcher SA; Sterling JA
    Clin Exp Metastasis; 2014 Dec; 31(8):945-59. PubMed ID: 25359619
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A kinase-defective transforming growth factor-beta receptor type II is a dominant-negative regulator for human breast carcinoma MCF-7 cells.
    Ko Y; Koli KM; Banerji SS; Li W; Zborowska E; Willson JK; Brattain MG; Arteaga CL
    Int J Oncol; 1998 Jan; 12(1):87-94. PubMed ID: 9454891
    [TBL] [Abstract][Full Text] [Related]  

  • 57. TGF-beta gene expression depends on tissue architecture.
    Theodorescu D; Sheehan C; Kerbel RS
    In Vitro Cell Dev Biol; 1993 Feb; 29A(2):105-8. PubMed ID: 8473265
    [No Abstract]   [Full Text] [Related]  

  • 58. [The role of transforming growth factors in the growth control of cancer cells].
    Hirai R
    Tanpakushitsu Kakusan Koso; 1991 May; 36(7):1357-63. PubMed ID: 1651542
    [No Abstract]   [Full Text] [Related]  

  • 59. The role of TGF-beta and Wnt signaling in gastrointestinal stem cells and cancer.
    Mishra L; Shetty K; Tang Y; Stuart A; Byers SW
    Oncogene; 2005 Aug; 24(37):5775-89. PubMed ID: 16123810
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Transforming growth factor beta stimulation of colorectal cancer cell lines: type II receptor bypass and changes in adhesion molecule expression.
    Ilyas M; Efstathiou JA; Straub J; Kim HC; Bodmer WF
    Proc Natl Acad Sci U S A; 1999 Mar; 96(6):3087-91. PubMed ID: 10077641
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.